In the BioHarmony Drug Report Database
Adefovir dipivoxil
Hepsera (adefovir dipivoxil) is a small molecule pharmaceutical. Adefovir dipivoxil was first approved as Hepsera on 2002-09-20. It is used to treat chronic hepatitis b and hepatitis b in the USA. It has been approved in Europe to treat chronic hepatitis b.
Trade Name
|
Hepsera |
|---|---|
Common Name
|
adefovir dipivoxil |
ChEMBL ID
|
CHEMBL922 |
Indication
|
chronic hepatitis b, hepatitis b |
Drug Class
|
Antivirals |
Image (chem structure or protein)